Giuseppe Morgante

ORCID: 0000-0001-5024-2321 · 13 papers in corpus · active 1996-2020

Study types

  • article 7
  • review 3
  • other 2
  • letter 1

Condition tags

  • endometriosis 5
  • chronic_pelvic_pain 2
  • infertility 1
article 2020
·doi:10.1080/13625187.2020.1736546

Our study showed that DNG exerted an important stimulatory effect on SHBG concentrations, which was less than that of DRSP but greater than that of CMA. Similar results were also obtained for dehydroepiandrosterone sulphate and total testos…

other 2020
Cells ·doi:10.3390/cells9051121

Embryo implantation has been defined as the "black box" of human reproduction. Most of the knowledge on mechanisms underlining this process derives from animal models, but they cannot always be translated to humans. Therefore, the developme…

other 2018
Journal of psychosomatic obstetrics and gynaecology ·doi:10.1080/0167482X.2017.1386171

INTRODUCTION: Endometriosis is a gynecological disease with a severe impact on quality of life. The aim of this study is to assess mental health status in a group of women with endometriosis, investigating their clinical history, pain sympt…

review 2018
Minerva ginecologica ·doi:10.23736/s0026-4784.17.04172-7

Vitamin D or calcitriol, which was first identified back in 1920, has a key role in bone metabolism and mineralization, and in calcium and magnesium homeostasis. A nuclear receptor (VDR) mediates vitamin D actions in a lot of organs like bo…

review 2016
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2016.05.032
article 2013
·doi:10.1016/j.contraception.2012.09.003
letter 2003
·doi:10.1016/s0015-0282(03)00070-0
review 2002
·doi:10.2165/00002018-200225110-00002
article 1999
Human Reproduction ·doi:10.1093/humrep/14.9.2371

The most effective therapy for endometriosis is a matter for debate. The aim of the present randomized study was to evaluate the efficacy of low doses of danazol on recurrence of pelvic pain in patients with moderate or severe endometriosis…

article 1999
·doi:10.1159/000010118

The aim of this study was to evaluate the effects of danazol in reducing the volume of fibromyomas and in the treatment of associated symptoms. Twenty women (34-42 years) with uterine fibromyomas were treated with 400 mg/day of danazol for …

article 1998
article 1997
·doi:10.1093/humrep/12.2.357

We report the results of administration of danazol after suspension of gonadotrophin-releasing hormone analogue (GnRHa) therapy for uterine myomas. A total of 21 women with uterine myomas was treated with 100 mg danazol for 6 months after G…

article 1996

Uterine fibromyomatosis is a widely recognised and well studied pathology that is found in around 30% of over 35-year-old women. It has been extensively demonstrated that the etiology of fibromyomas is hormone dependent and to date the main…